Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE : revenue, balance sheet and financial ratios

SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE is a French company founded 10 years ago, specialized in the sector Fonds de placement et entités financières similaires. Based in L'ISLE-D'ESPAGNAC (16340), this company of category PME shows in 2024 a net income positive of 254 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE (SIREN 812350650)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 253 862 € 382 212 € 369 470 € 271 247 € 266 936 € 263 801 € 223 194 € 115 176 €
EBITDA -1 959 € -3 010 € -2 054 € -1 772 € -1 722 € -1 985 € -1 911 € -2 115 €
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE generates positive net income of 254 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 115 k€ -> 254 k€.

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-1 959 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-1 959 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

253 862 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 18%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 84%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.8 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

18.437%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

83.662%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

1.805

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

100.0%

Solvency indicators evolution
SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE

Sector positioning

Debt ratio
18.44 2024
2022
2023
2024
Q1: 0.01
Med: 13.69
Q3: 116.56
Average -5 pts over 3 years

In 2024, the debt ratio of SPFPLARL DE PHARMACIENS D... (18.44) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
83.66% 2024
2022
2023
2024
Q1: 13.95%
Med: 55.8%
Q3: 90.35%
Good +13 pts over 3 years

In 2024, the financial autonomy of SPFPLARL DE PHARMACIENS D... (83.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
1.8 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.15 years
Q3: 4.69 years
Average

In 2024, the repayment capacity of SPFPLARL DE PHARMACIENS D... (1.80) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 2537.22. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

2537.223

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-456.508

Liquidity indicators evolution
SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE

Sector positioning

Liquidity ratio
2537.22 2024
2022
2024
Q1: 132.35
Med: 897.73
Q3: 5412.13
Good -16 pts over 2 years

In 2024, the liquidity ratio of SPFPLARL DE PHARMACIENS D... (2537.22) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
-456.51x 2024
2022
2023
2024
Q1: -144.56x
Med: -8.16x
Q3: 0.0x
Average

In 2024, the interest coverage of SPFPLARL DE PHARMACIENS D... (-456.5x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Positioning of SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE in its sector

Comparison with sector Fonds de placement et entités financières similaires

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (26 transactions). This range of 713 015€ to 4 919 488€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2024
Indicative
713k€ 3294k€ 4919k€
3 294 555 € Range: 713 015€ - 4 919 488€
NAF 5 année 2024

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 26 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fonds de placement et entités financières similaires)

Compare SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE with other companies in the same sector:

Voir toutes les statistiques du secteur Fonds de placement et entités financières similaires

Frequently asked questions about SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE

What is the revenue of SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE ?

The revenue of SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE profitable?

Yes, SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE generated a net profit of 254 k€ in 2024.

Where is the headquarters of SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE ?

The headquarters of SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE is located in L'ISLE-D'ESPAGNAC (16340), in the department Charente.

Where to find the tax return of SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE ?

The tax return of SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE operate?

SPFPLARL DE PHARMACIENS D'OFFICINE-GERALDINE BREVIERE operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.